Vimal Mehta - Net Worth and Insider Trading
Vimal Mehta Net Worth
The estimated net worth of Vimal Mehta is at least $23 Million dollars as of 2024-04-29. Vimal Mehta is the CEO and President of BioXcel Therapeutics Inc and owns about 8,592,314 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $23 Million. Details can be seen in Vimal Mehta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vimal Mehta has not made any transactions after 2024-04-04 and currently still holds the listed stock(s).
Transaction Summary of Vimal Mehta
Vimal Mehta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vimal Mehta owns 1 companies in total, including BioXcel Therapeutics Inc (BTAI) .
Click here to see the complete history of Vimal Mehta’s form 4 insider trades.
Insider Ownership Summary of Vimal Mehta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2024-04-04 | director & CEO & President & Secretary |
Vimal Mehta Latest Holdings Summary
Vimal Mehta currently owns a total of 1 stock. Vimal Mehta owns 8,592,314 shares of BioXcel Therapeutics Inc (BTAI) as of April 4, 2024, with a value of $23 Million.
Latest Holdings of Vimal Mehta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2024-04-04 | 8,592,314 | 2.63 | 22,597,786 |
Holding Weightings of Vimal Mehta
Vimal Mehta Form 4 Trading Tracker
According to the SEC Form 4 filings, Vimal Mehta has made a total of 9 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years, including 3 buys and 6 sells. The most-recent trade in BioXcel Therapeutics Inc is the sale of 5,268 shares on April 4, 2024, which brought Vimal Mehta around $13,802.
Insider Trading History of Vimal Mehta
- 1
Vimal Mehta Trading Performance
GuruFocus tracks the stock performance after each of Vimal Mehta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vimal Mehta is 30.96%. GuruFocus also compares Vimal Mehta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vimal Mehta within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vimal Mehta's insider trading performs compared to the benchmark.
Performance of Vimal Mehta
Average Return
150.23%
Outperforming Transactions
88%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.68 | 30.96 | 164.44 | 150.23 | 136.45 | 48.95 |
| Relative Return to S&P 500(%) | 12.33 | 26.33 | 155.81 | 136.16 | 119.92 | 32.62 |
Vimal Mehta Ownership Network
Ownership Network List of Vimal Mehta
Ownership Network Relation of Vimal Mehta
Vimal Mehta Owned Company Details
What does BioXcel Therapeutics Inc do?
Who are the key executives at BioXcel Therapeutics Inc?
Vimal Mehta is the director & CEO & President & Secretary of BioXcel Therapeutics Inc. Other key executives at BioXcel Therapeutics Inc include CHIEF COMMERCIAL OFFICER Matthew T. Wiley , Chief Financial Officer Richard I Steinhart , and Chief Scientific Officer Frank Yocca .
BioXcel Therapeutics Inc (BTAI) Insider Trades Summary
Over the past 18 months, Vimal Mehta made 5 insider transaction in BioXcel Therapeutics Inc (BTAI) with a net sale of 196,268. Other recent insider transactions involving BioXcel Therapeutics Inc (BTAI) include a net sale of 180,000 shares made by Krishnan Nandabalan , a net sale of 52,052 shares made by Frank Yocca , and a net sale of 30,723 shares made by Vincent O'neill .
In summary, during the past 3 months, insiders sold 9,589 shares of BioXcel Therapeutics Inc (BTAI) in total and bought 0 shares, with a net sale of 9,589 shares. During the past 18 months, 471,951 shares of BioXcel Therapeutics Inc (BTAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 471,951 shares.
BioXcel Therapeutics Inc (BTAI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioXcel Therapeutics Inc Insider Transactions
Vimal Mehta Mailing Address
Above is the net worth, insider trading, and ownership report for Vimal Mehta. You might contact Vimal Mehta via mailing address: 780 East Main Street, C/o Bioxcel Therapeutics, Inc., Branford Ct 06405.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
